Weedstocks Newswire Feed
New Technology Platforms Dramatically Increase Cannabinoid Yields
LOS ALAMOS, N.M., June 25, 2019 /CNW/ -- Trait Biosciences Inc. ("Trait" or the "Company"), the largest integrated bio-technology innovator in the cannabis industry, today announced the US Patent and Trademarks Office ("USPTO") has allowed it patent protection for breakthrough technology platforms that produce truly water-soluble cannabinoids and dramatically increase cannabinoid yields in hemp and cannabis.
The USPTO granted allowance for the Company's Patent Application 16/110,728 entitled "High Level In Vivo Biosynthesis and Isolation of Water-Soluble Cannabinoids in Plant Systems" (the "Patent"). The Patent, which was applied for in August 2018 and allowed in just under one year, gives Trait robust protection over all key technological components for its Distilled™ and Amplified™ technologies.
"This is another pivotal day for us," said Dr. Richard Sayre, Chief Science Officer of Trait. "The allowance of this Patent gives us robust protection over two of our platform technologies — Trait Distilled™ and Trait Amplified™ — which, we are confident, will change the future of the cannabis and hemp industries."
Sayre added: "What makes the allowance of this Patent more gratifying is the scope of protection that the USPTO has given us — the Patent covers every gene/enzyme from all organisms claimed in the Patent. It is uncommon for the USPTO to grant such broad protection over classes of genes and enzymes in this manner. It is a testament to the hard work, innovation and experience of our science team, and the excellent IP strategy that has been developed by our IP counsel."
BOGOTA, Colombia, June 25, 2019 /CNW/ - CannabCo Pharmaceutical Corp. Colombia S.A.S. (CannabCo Colombia), a Colombia based cannabis cultivator and manufacturer of medical cannabis products, is pleased to announce that it has signed an LOI for the provisioning of 7000 kg per annum of non psychoactive (<1% THC), and 5000 kg per annum of psychoactive cannabis oil in a variety of formats. Products would include oil in 30-60 ml bottles of varying concentrations, capsules, and topical creams both in CBD (non psychoactive) and THC/CBD (psychoactive) formats.
The LOI represents the initial production on an annual supply agreement and is estimated in value to be in excess of $70MM USD per annum. Parties intend to increase allocation and supply based on market development in the targeted region.
Production will occur in Colombia at CannabCo's extraction, production and processing facility located 30 minutes outside of the country's capital city of Bogota.
"We are very excited to be part of Colombia's efforts to become the world leader in medical cannabis supply" said Joseph Palumbo, the country general manager. "We have been inundated with supply requests for a market that is grossly underserviced and under-producing currently, and we are looking forward to ramping up to meet the demand over the next few years. We believe that Colombia with its perfect growing climate and dedication to the medical cannabis market will be the primary source of medical cannabis on a global scale."
CannabCo could not be more pleased with the supply agreement or its decision to enter the Colombian cannabis market. "With its near perfect growing conditions for cannabis, abundant and educated low cost labour force, and already established agricultural footprint, Colombia is the perfect place for our cannabis cultivation and product manufacturing efforts" said Joseph.
VANCOUVER, June 25, 2019 /CNW/ - Cannachiefs.ca is home to the annual "TOP 50 Most Influential Canna Chief" exclusive profiles. Our Top 50 Most Influential Canna Chiefs of 2019 are an elite group drawn from the larger pool of Canna Chief honorees each year that represent the cream of the Cannabis Industry business leaders' crop - who drive revenue and partner strategies and evangelize the importance of partnerships.
All Canna Chief honorees are selected by CannaChief Media's editorial staff based on their professional achievements, standing in the industry, dedication to the partner community and strategies in driving future growth and innovation. The complete 2019 Canna Chiefs Top 50 list is featured online here.
Chuck Rifici, Chairman & CEO at Auxly Cannabis Group has been honored as the 2019 Canna Chief of the Year. Chuck Rifici is a pioneer of the North American cannabis industry having created and managed opportunities that have positively impacted the Canadian landscape. Chuck has founded and been involved in the creation of some of Canada's largest and most successful cannabis efforts. He is best known for having co-founded Canopy Growth Corporation (formerly Tweed Marijuana Inc.).
Today, Chuck is Chairman and CEO of Auxly Cannabis Group, a platform spanning the entire cannabis value-chain, minimizing risk while simultaneously maximizing exposure to multiple, geographically-diverse cannabis companies through a single source, and Founder and CEO of Nesta Holding Co., a private equity firm that creates wide ranging partnerships and brands within the cannabis industry
When Chuck was informed that he was selected as the 2019 Canna Chief of the Year, he was thrilled. Chuck said, "I am thrilled to accept the 2019 Canna Chief of the Year. This comes at an important time, for myself, but also for advocates and our industry. 2018 was a historic year, so many have contributed a great deal of time, energy and passion to this industry. I accept this honour with pride and will remain committed and eager to explore new opportunities and projects that give back to the consumer in a way we can be extremely proud of."
VANCOUVER, June 25, 2019 /CNW/ - 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE: TGIF) (OTCQX: TGIFF), a vertically integrated cannabis consumer packaged goods company that owns licensed cultivation and manufacturing assets to support its brands, announces that it will report its financial results for the third quarter period ending April 30, 2019 on July 2, 2019.
About 1933 Industries Inc.
1933 Industries Inc. is a vertically integrated cannabis company with operations in the United States and Canada. 1933 Industries owns licensed medical and adult-use cannabis cultivation and production assets, proprietary hemp-based, CBD infused products, CBD extraction services and a specialized cannabis advisory firm. Our proprietary brands include AMA, Canna Hemp™, Canna HempX™, Canna Fused™, Canna Hemp Paws™, and Nineteen 33 THC. Birdhouse Skateboards™, OG DNA Genetics, Denver Dab Co., The Real Kurupt's Moon Rocks and Gotti's Gold under licensing agreements.
About Canna Hemp™ Canna Hemp™ CBD Relief Cream was named "Best Topical" by Leafy's Best in State: The Top State Specific Products and Experiences of 2018. Infused's award-winning transdermal Pain Relief Cream delivers fast-acting targeted relief to areas of discomfort, combating inflammation, arthritis joint pain, backaches, muscles spasms, strains, bruises, cramps, and headaches. http://www.cannahemp.com https://www.leafly.com/news/strains-products/best-in-state-2018-nevada-cannabis
About Canna HempX™ Canna Hemp X™ was named "Best Topicals for Pain" by Herb's Guide to the Best Cannabis Products on the Planet. Canna Hemp X™ is a CBD sports recovery cream for athletes to help focus on recovery and wellness. From soothing pain, aiding with muscle spasms, healing assistance for bruises, injuries, or arthritis relief, Canna Hemp X™ bridges the gap between recovery and top performance.
Supreme Cannabis Launches Premium Cannabis Oil in Partnership with Wiz Khalifa and Khalifa Kush Enterprises Canada
TORONTO, June 25, 2019 /CNW/ - The Supreme Cannabis Company, Inc. ("Supreme Cannabis" or the "Company") (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), in partnership with Khalifa Kush Enterprises Canada ULC ("KKE"), today launched KKE Oil, the first product under the KKE brand line.
KKE Oil is a premium, recreational focused oil, developed for the consumer who wants the convenience, high THC potency and precise dosing offered by a cannabis oil. KKE Oils are one of the first ever recreational-focused cannabis oils available to consumers in Canada. Wiz Khalifa and the KKE team specifically selected the Supreme Cannabis' wholly-owned subsidiary, 7ACRES Sensi Star strain for the debut of the line.
"I'm excited to bring our first products to Canada and launch KKE Oils. They are an awesome, high-in-THC product that everyone will love," said Wiz Khalifa, principal of KKE. "This is a legendary moment that will be followed by many more game changing releases KKE will launch with Supreme Cannabis over the next year.
"We firmly believe that a high-quality input supports high-quality output and KKE Oil embodies this belief. We are excited to launch one of the first recreational focused cannabis oils in Canada with Wiz Khalifa and the KKE team. KKE Oils are easy to consume, effective and deliver the aromatic terpene profile 7ACRES' Sensi Star is known for. We can't wait to launch the full suite of KKE products, including KKE Jean Guy Oil, later this year," said John Fowler, President and Founder of Supreme Cannabis.
(Photo: Business Wire)
NANAIMO, British Columbia--(BUSINESS WIRE)--Tilray Inc. (NASDAQ:TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced it has imported medical cannabis oral solutions in bulk into the United Kingdom from its Good Manufacturing Practices (GMP)-certified facility in Canada. This export allows Tilray to provide authorized U.K. patients in need with a locally maintained supply of medical cannabis oral solutions.
In September 2018, Tilray announced the successful import of Tilray 2:100 medical cannabis oil for a pediatric patient in need in the United Kingdom. Tilray’s 2:100 cannabis oil was supplied via a government-approved special access program following the U.K. Home Secretary’s historic announcement that declared prescriptions of cannabis-derived medicines legal for patients with an exceptional clinical need.
“As demand ramps up in the U.K., Tilray is well positioned to be a leading supplier of medical cannabis products,” says Sascha Mielcarek, Managing Director of Tilray Europe. “Regulations are progressing as more and more countries across Europe are recognizing the benefits of medical cannabis and its potential to improve patients’ quality of life. We’re pleased to reaffirm our commitment to delivering medical cannabis to patients in the U.K. and look forward to offering a variety of GMP-certified, pharmaceutical-grade products in the coming months.”
(Photo: Business Wire)
NANAIMO, British Columbia--(BUSINESS WIRE)--Tilray Inc. (NASDAQ:TLRY), ein globaler Vorreiter im Bereich Cannabis-Forschung, -Anbau, -Produktion und -Vertrieb, gab heute bekannt, dass es medizinische Cannabisöl-Lösungen en gros von seiner kanadischen GMP (gute Herstellungspraktiken)-zertifizierte Einrichtung in Großbritannien importiert hat. Mit diesem Export kann Tilray berechtigten britischen Patienten bei Bedarf einen vor Ort unterhaltenen Vorrat medizinischer Cannabislösungen für die orale Anwendung bereitstellen.
Im September 2018 gab Tilray den erfolgreichen Import von Tilray 2:100 medizinischem Cannabisöl für einen pädiatrischen Patienten in Großbritannien bekannt. Die Bereitstellung von 2:100 Cannabisöl von Tilray erfolgte im Rahmen eines staatlich zugelassenen Sonderzugangsprogramms nach der historischen Bekanntgabe des britischen Innenministers, in der die Rechtmäßigkeit der Verschreibung von Medikamenten aus Cannabis bei Patienten mit außergewöhnlichen klinischen Bedarf verkündet wurde.
„Bei steigender Nachfrage in Großbritannien ist Tilray für eine künftige Rolle als führender Lieferant von medizinischen Cannabisprodukten gut gerüstet“, so Sascha Mielcarek, Managing Director von Tilray Europe. „Die Bestimmungen sind im Wandel begriffen und immer mehr Länder in ganz Europa erkennen jetzt den Nutzen von medizinischem Cannabis und dessen Potential zur Verbesserung der Lebensqualität von Patienten an. Wir bekräftigen unsere Zusage zur Bereitstellung von medizinischem Cannabis für Patienten in Großbritannien und freuen uns darauf, eine Reihe von GMP-zertifizierten Pharmaprodukten in den kommenden Monaten anzubieten.”
Accomplished marketing executive brings consumer-focused experience from iconic brands
COLUMBUS, OH, June 25, 2019 /CNW/ - Green Growth Brands, Inc. (CSE: GGB) (OTCQB: GGBXF) (GGB or the Company) is pleased to announce the appointment of Jann Parish as Chief Marketing Officer (CMO), effective immediately. Parish, formerly CMO of Victoria's Secret and other global brands, brings brand development, strategic consumer relationship management and digital innovation expertise to the Company.
"As GGB continues rapid expansion in both the CBD and MSO segments, we are delighted to be bringing Jann, a proven consumer marketing expert, onboard," said Peter Horvath, CEO of Green Growth Brands. "Jann is a master at positioning brands to resonate with consumers. As we scale our portfolio of brands, I am confident that under her leadership we will be differentiated from the competition. We are so pleased to welcome Jann to the team."
In prior roles Parish has displayed her talent for driving meaningful results through consumer initiatives, building and evolving brands and leading high-performing teams. Parish was most recently at Victoria's Secret as CMO. Prior to Victoria's Secret, Parish was with PVH Corporation, working with global brands Calvin Klein and Tommy Hilfiger in a variety of leadership roles. While at Calvin Klein, she led the re-positioning of the Calvin Klein brand, most notably shifting the brand voice and marketing content to appeal to the millennial consumer. These efforts led to the development of the highly successful social media campaign, #mycalvins, which is still in use today, and resulted in more than three-times growth in the women's intimates space within two years.
"I am thrilled to be joining the GGB team at such a pivotal moment as we launch brands across the cannabis and CBD space," said Parish. "I am excited to lead the way Green Growth Brands speaks to consumers, through an authentic and inclusive voice. We'll establish a new benchmark of branding and marketing, designed to resonate with the expected 14 million new users in cannabis, while maintaining loyalty with our existing consumers."
Lifestyle Delivery Systems Inc. Announces CSPA Group, Inc. and CannaStrips™ to Sponsor the Adelanto Cannabis Job Fair
VANCOUVER, British Columbia, June 25, 2019 /CNW/ -- Lifestyle Delivery Systems Inc. (CSE: LDS), (OTCQX: LDSYF), (Frankfurt: LD6, WKN: A14XHT) ("LDS" or the "Company") is pleased to announce that the City of Adelanto, where the Company's state-of-the-art facilities are located, is hosting a Cannabis Job Fair on June 25, 2019, and CannaStrips™ is one of the sponsors.
The City of Adelanto is hosting a Cannabis Job Fair today at the Adelanto Stadium in an effort to place eligible individuals over the age of 21 into employee positions within Adelanto's expanding cannabis industry. The Job Fair's goal is to connect Adelanto residents with cannabis companies looking to fill experienced and trainee positions in the cannabis field. The event is scheduled to begin at 10 a.m. and conclude at 4 p.m. All individuals looking for employment in the cannabis industry are welcome to attend. The LDS subsidiaries are both sponsoring the Job Fair and encouraging individuals to visit the CannaStrips™ booth to apply for positions with LDS subsidiaries. LDS subsidiaries have job openings in Cultivation, Nursery, Plant Genetics, Transportation, Distribution, Manufacturing, Products Sales and Marketing.
The Company's CEO, Brad Eckenweiler, stated, "We are very encouraged by the active role that the city has taken under the leadership of Mayor Reyes and Mayor Pro Tem Stevevonna Evans. It is the kind of effort that will make a positive impact on the City's unemployment issues. The LDS subsidiaries are excited to meet new applicants that hopefully will become new employees."
The Company will continue to update the market on all events as they become relevant.
About CSPA Group, Inc.